Deflazacort
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 560 publications
Acute methotrexate toxicity with severe oral ulcerations following inadvertent ingestion: a case report.
Journal: General dentistry
Published: October 28, 2026
The annexin A1 mimetic peptide Ac2-26 promotes inflammation-resolution and stimulates skeletal muscle regeneration in the mdx mouse model of Duchenne muscular dystrophy.
Journal: bioRxiv : the preprint server for biology
Published: October 25, 2026
Disease progression and economic burden of duchenne muscular dystrophy: A retrospective study using Swedish register data.
Journal: Journal of neuromuscular diseases
Published: July 04, 2026
A structured approach to address variability in the global management of adrenal insufficiency in Duchenne muscular dystrophy: the 2025 PJ Nicholoff steroid protocol.
Journal: Frontiers in neurology
Published: July 02, 2026
Muscle function, linear growth, and bone health during 30 months of vamorolone, prednisone, and deflazacort treatment for Duchenne muscular dystrophy: a comparative study.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: June 04, 2026
Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial.
Journal: Neurology
Published: May 27, 2026
Effects of Sex and Fed State Differences on the Pharmacokinetics of Drugs in Humans.
Journal: Drug research
Published: May 12, 2026
Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy.
Journal: BMC pharmacology & toxicology
Published: April 17, 2026
Balancing Benefits and Risks: Long-term Use of Daily versus Intermittent Corticosteroids in Duchenne Muscular Dystrophy.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 02, 2026
Molecular Hybrids of Deflazacort and H2S Donors: From Bench to Potential Treatment for Duchenne Muscular Dystrophy.
Journal: Journal of medicinal chemistry
Published: April 02, 2026
Last Updated: 11/08/2026